1 / 11

Balloons

Balloons. Hishiba K. Gastro Endo Clin N Am. 2007. Meta-analysis of BIB data. Imaz I. et al . Obes Surg. 2008. 3442 pts with BIB 0.8% obstruction 0.1% perforation 2 patients died from perforation 4.2 % removed before 6 months 32.1% Excess Body Weight Loss(EBWL) at 6 mos.

Download Presentation

Balloons

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Balloons Hishiba K. Gastro Endo Clin N Am. 2007

  2. Meta-analysis of BIB data Imaz I. et al . Obes Surg. 2008 • 3442 pts with BIB • 0.8% obstruction • 0.1% perforation • 2 patients died from perforation • 4.2 % removed before 6 months • 32.1% Excess Body Weight Loss(EBWL) at 6 mos

  3. SPATZ (Adjustable Intragastric Balloon) Lopez-Nava : Ist International Symposium on Non Invasive Bariatric Techniques. Lyon France 2011 12 month pilot study 18 pt. 50% EBWL 26 kg (57.2 lb.)

  4. Gastric partition

  5. Gastroduodenojejunalbypass sleeve Sandler BJ et al. SurgEndosc. 2011

  6. Gastroduodenojejunalbypass sleeve • A prospective, single-center trial. • End points • safety and incidence of adverse events. • % excess weight loss and changes in comorbidities, • changes in hemoglobin A1c levels. Sandler BJ et al. SurgEndosc. 2011

  7. Gastroduodenojejunalbypass sleeve • 24 patients; Mean BMI 42 kg/m2. • Delivered in 22 of the 24 patients (92%) • 17 maintained it (77%) and completed the full 12-week trial. • 39.7% excess weight loss at 12 weeks. • 7 patients with preoperative diabetes mellitus all had normal blood glucose levels throughout the trial, and none required antihyperglycemic medications. Sandler BJ et al. SurgEndosc. 2011

  8. Duodenal Sleeve for DM

  9. Endoscopic plication

  10. Full Sense Bariatric Device Courtesy: Randal Baker, MD

  11. Full Sense Device • Reversible • Minimally Invasive Endoscopic • Implantation • Removal • Maintains G-E Junction Function How It Works • Pressure on Distal Esophagus and Proximal Stomach causes Satiety and Resultant Weight Loss • Device evokes normal neuro-humeral responses associated with fullness. • Device augments/amplifies normal filling sensation for the stomach

More Related